BioPharma Economic Impact in the US Economy

The BioPharma industry has experienced considerable growth in recent years and an increasing presence in the US economy. In the comprehensive study, “BioPharma Economic Impact in the US Economy,” Managing Director Robert Stoner and Director Jéssica Dutra demonstrate that the BioPharma industry in the United States provides significant value added to Gross Domestic Product (GDP), and everything from discovering drugs to developing, producing, and marketing them to patients contributes a significant “multiplier” effect on employment and earnings, and adds a major R&D presence in the United States and worldwide.

Read the report here.